Correlation Between Pharming Group and Koninklijke BAM

Can any of the company-specific risk be diversified away by investing in both Pharming Group and Koninklijke BAM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharming Group and Koninklijke BAM into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharming Group NV and Koninklijke BAM Groep, you can compare the effects of market volatilities on Pharming Group and Koninklijke BAM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharming Group with a short position of Koninklijke BAM. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharming Group and Koninklijke BAM.

Diversification Opportunities for Pharming Group and Koninklijke BAM

0.77

Correlation Coefficient

Pharming Group  Koninklijke BAM

Poor diversification

The 3 months correlation between Pharming and Koninklijke is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Pharming Group NV and Koninklijke BAM Groep in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Koninklijke BAM Groep and Pharming Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharming Group NV are associated (or correlated) with Koninklijke BAM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Koninklijke BAM Groep has no effect on the direction of Pharming Group i.e., Pharming Group and Koninklijke BAM go up and down completely randomly.

Pair Corralation between Pharming Group and Koninklijke BAM

Assuming the 90 days trading horizon Pharming Group is expected to generate 2.47 times less return on investment than Koninklijke BAM. In addition to that, Pharming Group is 1.88 times more volatile than Koninklijke BAM Groep. It trades about 0.08 of its total potential returns per unit of risk. Koninklijke BAM Groep is currently generating about 0.36 per unit of volatility. If you would invest  507.00  in Koninklijke BAM Groep on April 24, 2025 and sell it today you would earn a total of  229.00  from holding Koninklijke BAM Groep or generate 45.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Pharming Group NV  vs.  Koninklijke BAM Groep

Pharming Group NV

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Pharming Group NV are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Pharming Group sustained solid returns over the last few months and may actually be approaching a breakup point.

Koninklijke BAM Groep

Risk-Adjusted Performance

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Koninklijke BAM Groep are ranked lower than 28 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Koninklijke BAM sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharming Group and Koninklijke BAM

The main advantage of trading using opposite Pharming Group and Koninklijke BAM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharming Group position performs unexpectedly, Koninklijke BAM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Koninklijke BAM will offset losses from the drop in Koninklijke BAM's long position.

The idea behind Pharming Group NV and Koninklijke BAM Groep pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.